Novo Nordisk sues Hims & Hers over copycat weight-loss drugs
Shares in US company fall 16% after FDA announces investigation into unregulated medication
Other newsrooms on this story
· 5 sources
cnbc.com·
Hims & Hers falls 8% after Novo's legal threat. Here's the latest
Novo Nordisk pops 8% after Hims & Hers pulls copycat weight-loss pill
Novo Nordisk and Eli Lilly fall after Hims & Hers announce $49 copy of Wegovy pill
Novo Nordisk sues Hims & Hers over cheaper copycat versions of Wegovy pill, injections
upi.com·
Novo Nordisk suing Hims & Hers over ‘copycat’ weight loss drug - UPI.com
